These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 11526521)

  • 21. ICCVAM evaluation of the murine local lymph node assay. Conclusions and recommendations of an independent scientific peer review panel.
    Dean JH; Twerdok LE; Tice RR; Sailstad DM; Hattan DG; Stokes WS
    Regul Toxicol Pharmacol; 2001 Dec; 34(3):258-73. PubMed ID: 11754530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nothing is perfect, not even the local lymph node assay: a commentary and the implications for REACH.
    Basketter DA; McFadden JF; Gerberick F; Cockshott A; Kimber I
    Contact Dermatitis; 2009 Feb; 60(2):65-9. PubMed ID: 19207375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A chemical dataset for evaluation of alternative approaches to skin-sensitization testing.
    Gerberick GF; Ryan CA; Kern PS; Dearman RJ; Kimber I; Patlewicz GY; Basketter DA
    Contact Dermatitis; 2004 May; 50(5):274-88. PubMed ID: 15209809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of an ex vivo local lymph node assay to assess contact hypersensitivity potential.
    Piccotti JR; Kawabata TT
    J Immunotoxicol; 2008 Jul; 5(3):271-7. PubMed ID: 18830887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of association between interleukin-6 production by contact allergen-activated draining lymph node cells and lymphoproliferative activity.
    Lappin MB; Dearman RJ; Norval M; Kimber I
    Am J Contact Dermat; 1998 Mar; 9(1):34-9. PubMed ID: 9471985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contact and respiratory sensitizers can be identified by cytokine profiles following inhalation exposure.
    De Jong WH; Arts JH; De Klerk A; Schijf MA; Ezendam J; Kuper CF; Van Loveren H
    Toxicology; 2009 Jul; 261(3):103-11. PubMed ID: 19422874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The local lymph node assay: current position in the regulatory classification of skin sensitizing chemicals.
    Basketter DA; Gerberick GF; Kimber I
    Cutan Ocul Toxicol; 2007; 26(4):293-301. PubMed ID: 18058304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local lymph node assay: validation assessment for regulatory purposes.
    Gerberick GF; Ryan CA; Kimber I; Dearman RJ; Lea LJ; Basketter DA
    Am J Contact Dermat; 2000 Mar; 11(1):3-18. PubMed ID: 10684384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the sensitization potential of persulfate salts used for bleaching hair.
    Cruz MJ; De Vooght V; Muñoz X; Hoet PH; Morell F; Nemery B; Vanoirbeek JA
    Contact Dermatitis; 2009 Feb; 60(2):85-90. PubMed ID: 19207378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skin sensitization testing in potency and risk assessment.
    Kimber I; Basketter DA; Berthold K; Butler M; Garrigue JL; Lea L; Newsome C; Roggeband R; Steiling W; Stropp G; Waterman S; Wiemann C
    Toxicol Sci; 2001 Feb; 59(2):198-208. PubMed ID: 11158712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proliferative responses in the local lymph node assay associated with concomitant exposure to 1,4-phenylenediamine and methyldibromo glutaronitrile: evidence for synergy?
    Jowsey IR; Basketter DA; Irwin A
    Contact Dermatitis; 2008 Aug; 59(2):90-5. PubMed ID: 18759875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a peptide reactivity assay for screening contact allergens.
    Gerberick GF; Vassallo JD; Bailey RE; Chaney JG; Morrall SW; Lepoittevin JP
    Toxicol Sci; 2004 Oct; 81(2):332-43. PubMed ID: 15254333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The reduced local lymph node assay: the impact of group size.
    Ryan CA; Chaney JG; Kern PS; Patlewicz GY; Basketter DA; Betts CJ; Dearman RJ; Kimber I; Gerberick GF
    J Appl Toxicol; 2008 May; 28(4):518-23. PubMed ID: 17879259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-enzymatic glutathione reactivity and in vitro toxicity: a non-animal approach to skin sensitization.
    Aptula AO; Patlewicz G; Roberts DW; Schultz TW
    Toxicol In Vitro; 2006 Mar; 20(2):239-47. PubMed ID: 16112535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compilation of historical local lymph node data for evaluation of skin sensitization alternative methods.
    Gerberick GF; Ryan CA; Kern PS; Schlatter H; Dearman RJ; Kimber I; Patlewicz GY; Basketter DA
    Dermatitis; 2005 Dec; 16(4):157-202. PubMed ID: 16536334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The identification of photoallergic potential in the local lymph node assay.
    Scholes EW; Basketter DA; Lovell WW; Sarll AE; Pendlington RU
    Photodermatol Photoimmunol Photomed; 1991 Dec; 8(6):249-54. PubMed ID: 1823150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Qualitative and quantitative evaluation of a local lymph node assay based on ex vivo interleukin-2 production.
    Azam P; Peiffer JL; Ourlin JC; Bonnet PA; Tissier MH; Vian L; Fabre I
    Toxicology; 2005 Jan; 206(2):285-98. PubMed ID: 15588920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of sensitive mouse lymph node assay for detection of contact sensitization capacity of dyes.
    Ikarashi Y; Tsuchiya T; Nakamura A
    J Appl Toxicol; 1996; 16(4):349-54. PubMed ID: 8854222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methyldibromoglutaronitrile: skin sensitization and quantitative risk assessment.
    Basketter DA
    Cutan Ocul Toxicol; 2010 Mar; 29(1):4-9. PubMed ID: 19883218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extrapolating local lymph node assay EC3 values to estimate relative sensitizing potency.
    Ryan CA; Chaney JG; Gerberick GF; Kern PS; Dearman RJ; Kimber I; Basketter DA
    Cutan Ocul Toxicol; 2007; 26(2):135-45. PubMed ID: 17612980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.